Given that patients treated perioperatively with pirfenidone displayed reduced serum KL-6 levels and reduced intensity of lung injury in resected specimens, it may be possible that the agent exerts its effect by suppressing the perioperative activity of IPF [57,58]. Here, MUC1 is linked to idiopathic pulmonary fibrosis.